Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
Is pulmonary artery denervation via a therapeutic intravascular ultrasonic system a safe and effective treatment option for patients with PAH? In this Q&A, Alex Rothman, BM BCh, PhD, highlights what he and...
Patients with pulmonary arterial hypertension may experience sleep disturbance and poor sleep quality. Lea Ann Matura, PhD, RN, answers our questions about the association between sleep and biomarkers among...
